查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585685

雙磷酸鹽藥品市場：依治療領域、給藥方式、應用、通路 - 2025-2030 年全球預測

Bisphosphonates Market by Therapeutic Areas (Cancer, Degenerative Bone Diseases), Mode of Delivery (Intravenous, Oral), Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年雙磷酸鹽藥品市值為24.6億美元，預計到2024年將達到25.5億美元，複合年成長率為3.75%，到2030年將達到31.8億美元。

雙磷酸鹽藥物是一類用於預防和治療骨質疏鬆症和類似骨相關疾病的藥物，主要透過抑制骨吸收和更新。世界人口老化以及骨質疏鬆症和其他骨骼病患病率的上升加劇了這項需求。應用範圍廣泛，包括治療停經後婦女的骨質疏鬆症、預防接受慢性類固醇治療的患者骨折、治療癌症患者的骨轉移。最終用途包括醫院、診所和家庭保健。影響成長的關鍵因素包括骨質疏鬆症管理意識的提高、藥物配方的進步以及醫療保健支出的增加。新的商機在於雙磷酸鹽藥物在罕見骨骼疾病治療中的擴大使用，以及緩釋性製劑等藥物傳遞系統的潛在開發，以提高患者的依從性。然而，阻礙生長的挑戰包括胃腸道疾病和下顎骨壞死等副作用，以及嚴格的監管調整，這可能會延遲新藥的推出。由於替代療法（包括新生物製藥和單株抗體）的競爭也存在局限性，這可能促使雙磷酸鹽的使用需要進一步創新。在創新方面，存在機會研究具有更高功效和減少副作用的雙磷酸鹽類似物，以及探索可能具有協同效應的聯合治療方法。此外，可以即時了解患者​​依從性和反應的數位健康監測工具可以補充雙磷酸鹽治療。該市場競爭激烈，其特點是製藥公司、學術界進行新研究以及在許可和聯盟方面採取戰略舉措的公司之間的合作。注重產品創新和交付方法的改進對於獲得市場佔有率至關重要。此外，您可以透過快速回應監管變化並透過策略規劃解決新的競爭威脅來顯著增強您的市場地位。

主要市場統計
基準年[2023] 24.6億美元
預測年份 [2024] 25.5億美元
預測年份 [2030] 31.8億美元
複合年成長率（%） 3.75%

市場動態：快速發展的雙磷酸鹽藥物市場的關鍵市場洞察

雙磷酸鹽藥物市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 各國老化率不斷上升
    • 加大投資改善醫療基礎設施
    • 改善報銷政策和醫療保健服務
  • 市場限制因素
    • 雙磷酸鹽類藥物的不良反應
  • 市場機會
    • 脊椎融合手術數量增加
    • 開發新藥領域的研究與開發
  • 市場挑戰
    • 意識淡薄，缺乏熟練的專業人員

波特五力：駕馭雙磷酸鹽藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解雙磷酸鹽藥物市場的外部影響

外部宏觀環境因素在塑造雙磷酸鹽藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解雙磷酸鹽藥物市場的競爭格局

對雙磷酸鹽藥品市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣雙磷酸鹽藥品市場供應商的績效評估

FPNV定位矩陣是評估雙磷酸鹽藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了雙磷酸鹽藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對雙磷酸鹽藥品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 經濟老化率上升
      • 加大投資改善醫療基礎設施
      • 改善報銷政策和醫療保健服務
    • 抑制因素
      • 雙磷酸鹽類藥物的不良反應
    • 機會
      • 脊椎融合手術增加
      • 開發新藥領域的研究與開發
    • 任務
      • 意識淡薄，缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療領域分類的雙磷酸鹽藥物市場

  • 癌症
    • 乳癌
    • 骨髓瘤
  • 骨退化性疾病
    • 低血鈣
    • 骨質疏鬆症

第7章 依給藥方式分類的雙磷酸鹽藥物市場

  • 靜脈
  • 口服

第8章雙磷酸鹽藥品市場：依應用分類

  • 婦科
  • 腫瘤學
  • 整形外科

第9章雙磷酸鹽藥品市場：依通路

  • 醫院
  • 線上管道
  • 零售藥房

第10章美洲雙磷酸鹽藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太雙磷酸鹽藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲雙磷酸鹽藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Apotex Inc.
  • Asahi Kasei Corp.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
Product Code: MRR-437D45957DAF

The Bisphosphonates Market was valued at USD 2.46 billion in 2023, expected to reach USD 2.55 billion in 2024, and is projected to grow at a CAGR of 3.75%, to USD 3.18 billion by 2030.

Bisphosphonates are a class of drugs primarily used to prevent and treat osteoporosis and similar bone-related conditions by inhibiting bone resorption and turnover. Their necessity is underscored by an aging global population and rising prevalence of osteoporosis and other bone diseases. The application scopes span across treating osteoporosis in postmenopausal women, preventing fractures in patients undergoing chronic steroid therapy, and addressing bone metastases in cancer patients. End-use scopes involve hospitals, clinics, and home healthcare settings. Key factors influencing growth include increasing awareness of osteoporosis management, advancements in drug formulations, and growing healthcare expenditure. Emerging opportunities lie in expanding applications for bisphosphonates in treating rare bone disorders and potential developments in drug delivery systems, such as extended-release formulations, to enhance patient compliance. However, challenges that impede growth include side effects like gastrointestinal issues, jaw osteonecrosis, and stringent regulatory adjustments, potentially delaying the introduction of new drug varieties. Limitations also arise from competition with alternative therapies, including newer biologics and monoclonal antibodies, possibly driving a need for further innovation in bisphosphonate use. In terms of innovation, opportunities exist in researching bisphosphonate analogs with enhanced efficacy and reduced side effects, and exploring combination therapy approaches that might offer synergistic benefits. Moreover, digital health monitoring tools providing real-time insights into patient adherence and response could complement bisphosphonate therapy. The market nature is highly competitive and is characterized by collaboration among pharmaceutical companies, academia for novel research, and entities making strategic moves in licensing and partnerships. Emphasis on both product innovation and enhanced delivery methods is essential for capturing market share. Moreover, adapting to regulatory changes swiftly and addressing emerging competitive threats through strategic planning can significantly bolster market positions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.46 billion
Estimated Year [2024] USD 2.55 billion
Forecast Year [2030] USD 3.18 billion
CAGR (%) 3.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bisphosphonates Market

The Bisphosphonates Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing rate of aging population in economies
    • Rising investments to improve healthcare infrastructure
    • Improving reimbursement policies and healthcare access
  • Market Restraints
    • Adverse effects of bisphosphonates
  • Market Opportunities
    • Rising number of spine fusion surgeries
    • R&D in the arena of novel drugs development
  • Market Challenges
    • Limited awareness and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Bisphosphonates Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bisphosphonates Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bisphosphonates Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bisphosphonates Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bisphosphonates Market

A detailed market share analysis in the Bisphosphonates Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bisphosphonates Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bisphosphonates Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bisphosphonates Market

A strategic analysis of the Bisphosphonates Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bisphosphonates Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Asahi Kasei Corp., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., Genentech, Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Bisphosphonates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapeutic Areas, market is studied across Cancer and Degenerative Bone Diseases. The Cancer is further studied across Breast Cancer and Myeloma. The Degenerative Bone Diseases is further studied across Hypocalcemia and Osteoporosis.
  • Based on Mode of Delivery, market is studied across Intravenous and Oral.
  • Based on Application, market is studied across Gynecology, Oncology, and Orthopedics.
  • Based on Distribution Channel, market is studied across Hospitals, Online Channels, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing rate of aging population in economies
      • 5.1.1.2. Rising investments to improve healthcare infrastructure
      • 5.1.1.3. Improving reimbursement policies and healthcare access
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of bisphosphonates
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of spine fusion surgeries
      • 5.1.3.2. R&D in the arena of novel drugs development
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bisphosphonates Market, by Therapeutic Areas

  • 6.1. Introduction
  • 6.2. Cancer
    • 6.2.1. Breast Cancer
    • 6.2.2. Myeloma
  • 6.3. Degenerative Bone Diseases
    • 6.3.1. Hypocalcemia
    • 6.3.2. Osteoporosis

7. Bisphosphonates Market, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Oral

8. Bisphosphonates Market, by Application

  • 8.1. Introduction
  • 8.2. Gynecology
  • 8.3. Oncology
  • 8.4. Orthopedics

9. Bisphosphonates Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Online Channels
  • 9.4. Retail Pharmacies

10. Americas Bisphosphonates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bisphosphonates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bisphosphonates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apotex Inc.
  • 2. Asahi Kasei Corp.
  • 3. Dr. Reddy's Laboratories Ltd.
  • 4. F. Hoffmann-La Roche Ltd.
  • 5. Genentech, Inc.
  • 6. Merck KGaA
  • 7. Novartis AG
  • 8. Pfizer Inc.
  • 9. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. BISPHOSPHONATES MARKET RESEARCH PROCESS
  • FIGURE 2. BISPHOSPHONATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BISPHOSPHONATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BISPHOSPHONATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BISPHOSPHONATES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BISPHOSPHONATES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BISPHOSPHONATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BISPHOSPHONATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BISPHOSPHONATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BISPHOSPHONATES MARKET DYNAMICS
  • TABLE 7. GLOBAL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BISPHOSPHONATES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BISPHOSPHONATES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BISPHOSPHONATES MARKET SIZE, BY HYPOCALCEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BISPHOSPHONATES MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BISPHOSPHONATES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BISPHOSPHONATES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BISPHOSPHONATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BISPHOSPHONATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. BISPHOSPHONATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. BISPHOSPHONATES MARKET, FPNV POSITIONING MATRIX, 2023